The Indian Council of Medical Research (ICMR), New Delhi, has called for Expressions of Interest (EoI) from interested organizations, companies, and manufacturers for the technology transfer of a new colorimetric isothermal LAMP assay for quick Monkeypox virus detection. The move is intended to promote faster commercialization and greater accessibility of this novel diagnostic tool.

Key Highlights:
ICMR Initiative to Enhance Monkeypox Surveillance:

• The National Institute of Virology (NIV), Pune, one of the ICMR institutes, has designed the LAMP-based diagnostic technology.

• The loop-mediated isothermal amplification (LAMP) assay is a cost-effective, rapid, and easy-to-use alternative to traditional molecular diagnostics.

• The tool will facilitate early detection and containment of Monkeypox cases, enhancing public health preparedness.

Technology Transfer for Commercialization

• ICMR invites industry partners to develop, produce, and market the diagnostic assay globally.

• The chosen company shall be granted rights for additional R&D, manufacturing, and marketing.

• The deadline for EoI submission is March 12, 2025. The interested companies may download information from ICMR's official website.

Potential Public Health Impact

• Considering the increasing global health threat posed by Monkeypox, early diagnosis is essential for the control of the outbreak.

• LAMP assay presents a portable, quicker, and more scalable diagnostic option than the conventional PCR-based techniques.

• Widespread commercialization will guarantee accessibility in national as well as global markets.

Quotes by Officials:
ICMR Representative:
"The technology transfer of this pioneering diagnostic tool will speed up Monkeypox surveillance and reinforce public health response. We hope to work with industry partners to enable widespread accessibility."Since Monkeypox is an ongoing global health issue, technology transfer from ICMR targets the closing the gap for real-time diagnostics. Companies who can submit proposals up to the end of March 12 are welcomed to take a step in driving this public health milestone.